FDA Grants Quick Review For 3 Psychedelic Drug Trials
An anonymous reader quotes a report from NBC News: The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. It’s the latest move by the Trump administration signaling a shift in policy toward treatments that also give users a high – coming a day aft … ⌘ Read more